Neurotech International Ltd (NTI) TRADING HALT SUSPENDED

20mins delayed

Movement

1 Year Return


Neurotech International Ltd Chart

Share price
Last
Change
Volume
Turnover
Market Cap $14.52 million
Today's Movement
Prev. Close
Open
Day Range -
VWAP
Historical Stats
52w Range -
4w Avg Volume
4w Avg Turnover
(delayed)

NTI Statistics

26 November

1,810 / 2,244

ASX Size Rank

1yr Return

vs Sector (1yr)

+49.48%

vs ASX 200 (1yr)

+64.24%

$14.52 million

Market Cap

Share Issue

500.66 million

All Ords (%)

N/A

Short Sold

0%

Current Fundamentals

26 November

N/A

PE Ratio

EPS ($)

-0.011

Earnings Yield

-38.28%

NTA ($)

-

0.00%

Dividend Yield

DPS ($)

-

Gross Div. Yield

-

Gross DPS ($)

-

Company Overview

Neurotech International Limited (NTI) researches, designs, markets and through third party manufacturers, produces wearable neurotechnology devices to assist with neurological conditions such as autism. Neurotech's current core focus is the design, manufacturing, sale and distribution of its first product, Mente, a portable electroencephalogram (EEG) medical device that uses neurofeedback to help relax the minds of children with autism spectrum disorder (ASD orautism).

Neurotech International Ltd Logo

Corporate Details

Head Office: Nedlands
Managing Director: -
GICS Sub-Industry: Health Care Equipment
Date Listed: 4 Nov 2016
Registry: Automic
Similar Companies: FPH / COH / RMD / ANN / NAN

Upcoming Calendar

23 Feb 2021 Report (Interim)
30 Aug 2021 Report (Prelim)
30 Aug 2021 Report (Annual)

Dividend History

Ex-Date Amount Franking Type Payable
No dividends paid in the last 5 years

See Upcoming Dividends for all ASX companies.

Announcements

Date Heading Pages File Size Time

Announcements provided by

Broker Consensus

The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.

NTI is not covered by a major broker,
or data from most recent compilation was omitted due
to not meeting QA guidelines.

Directors & Management

About the Data


Name Title Since Bio
Mr Winton William Willesee Non-Executive Director Apr 2019
Mr Brian Willoughby Leedman Non-Executive Chairman, Non-Executive Director Oct 2020
Mr Mark Davies Non-Executive Director Apr 2019

Director Transactions

About the Data

NTI directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
05/10/20 Winton Willesee Issued 6,047,382 $0.008 $48,500 Director remuneration.
05/10/20 Winton Willesee Transfer 1,252,852 $0.013 $16,287 Off-market transfer.
30/09/20 Peter Griffiths Issued 16,957,606 $0.008 $136,000 Director remuneration.
30/09/20 David Cantor Issued 4,551,122 $0.008 $36,499 Director remuneration.
30/09/20 Mark Davies Issued 7,793,017 $0.008 $62,499 Director remuneration.
18/11/19 Winton Willesee Buy +2,000,000 $0.014 $28,000 As advised by the company.
18/11/19 Peter Griffiths Buy +11,929,754 $0.014 $167,016 As advised by the company.
18/11/19 David Cantor Buy +2,000,000 $0.014 $28,000 As advised by the company.
18/11/19 Mark Davies Buy +2,000,000 $0.014 $28,000 As advised by the company.
25/02/19 Simon Trevisan Issued 3,333,334 $0.026 $86,666 Rights issue.
25/02/19 Simon Trevisan Issued 3,333,334 $0.030 $100,000 Rights issue.
25/02/19 Peter O'Connor Issued 503,100 $0.030 $15,093 Rights issue.
25/02/19 Peter O'Connor Issued 503,100 $0.026 $13,080 Rights issue.
25/02/19 Peter Griffiths Issued 2,634,790 $0.030 $79,043 Rights issue.
25/02/19 Peter Griffiths Issued 2,634,790 $0.026 $68,504 Rights issue.
04/12/18 David Cantor Issued 142,857 $0.140 $20,000 Issue of securities.
29/11/17 Wolfgang Storf Issued 471,277 $0.239 $112,864 Rights issue.
23/11/17 Adrian Trevisan Issued 411,371 $0.160 $65,819 Rights issue.

Shareholder Distribution

About the Data

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over Total Shareholders
No. of Shareholders 25 135 110 464 257 991

Top 20 Shareholders

About the Data

Name Shares Capital
J & J Bandy Nominees Pty Ltd 22,670,720 9.16%
Jalaver Pty Ltd 20,700,000 8.36%
Chincherinchee Nominees Pty Ltd 12,596,786 5.09%
Tribis Pty Ltd 8,738,434 3.53%
Citicorp Nominees Pty Limited 6,774,512 2.74%
Br Corporation Pty Ltd 5,925,000 2.39%
Clayton Capital Pty Ltd 5,000,000 2.02%
Siawade Pty Ltd 4,000,000 1.62%
Mr Bo He 3,652,290 1.48%
Surf Coast Capital Pty Ltd 3,250,000 1.31%
Miss Elisabeth Jane D'Sylva 3,200,000 1.29%
J & J Bandy Nominees Pty Ltd 3,000,000 1.21%
Mr Alexander Grech 2,965,624 1.20%
Empire Capital Partners Pty Ltd 2,859,012 1.16%
Comsec Nominees Pty Limited 2,456,178 0.99%
Windell Holdings Pty Ltd 2,315,000 0.94%
Tyf Holdings Pty Ltd 2,000,000 0.81%
Mr Rohan Charles Edmondson 2,000,000 0.81%
Mrs Sugandi Witharanage Rodrigo 2,000,000 0.81%
Robert Michael Baker 2,000,000 0.81%
Sabreline Pty Ltd 2,000,000 0.81%
Demasiado Pty Ltd 2,000,000 0.81%
Heritage Pacific Pty Ltd 2,000,000 0.81%
Hitmaster Pty Ltd 2,000,000 0.81%
Mr Bilal Ahmad 2,000,000 0.81%
Max Cap Investments Pty Ltd 2,000,000 0.81%
Flourish Super Pty Ltd 1,957,778 0.79%
Gianfam Investments Pty Ltd 1,900,000 0.77%
Mr Duncan Thain Craib 1,753,008 0.71%
All other shareholders 45.14 %


The Top 20 Shareholders of NTI hold 54.86% of shares on issue.

NTI Share Price History

Date Close Change % Change Open High Low Volume Turnover

NTI Historical Data

Download up to 20 years of share price history.


Year Closing Price (30 June) Last Trade
2020 $0.008 30 June
2019 $0.018 28 June
2018 $0.16 29 June
2017 $0.25 28 June

Offical data as published by ASX. See more Data Downloads.

Company Details

Principal Activity: Neurotech researches, designs, markets and through third party manufacturers, produces wearable neurotechnology devices to assist with neurological conditions such as autism.

Incorporated: --

Suite 5 CPC, 145 Stirling Hwy
Nedlands WA 6009


All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.